Aligned Genetics Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	14,618	10,139	14,927	10,696	6,137
Short-Term Investments	-	7,500	-	3,000	7,000
Cash & Short-Term Investments	14,618	17,639	14,927	13,696	13,137
Cash Growth	-17.13%	18.17%	8.99%	4.25%	8.22%
Accounts Receivable	2,623	2,855	2,667	1,451	2,130
Other Receivables	395.51	96.37	55.64	17.55	293.91
Receivables	3,079	3,331	2,723	1,469	2,424
Inventory	4,984	4,198	3,852	3,759	2,353
Prepaid Expenses	100.58	130.07	13.01	343.11	58.1
Other Current Assets	39.95	268.1	88.1	284.98	413.05
Total Current Assets	22,822	25,567	21,603	19,552	18,386
Property, Plant & Equipment	19,835	7,770	8,035	7,285	5,776
Long-Term Investments	7,880	8,058	8,584	7,233	7,744
Other Intangible Assets	202.04	131.53	31.03	64.35	101.08
Long-Term Deferred Tax Assets	2,194	1,842	2,064	2,043	1,780
Long-Term Deferred Charges	-	-	-	-	0
Other Long-Term Assets	4,801	858.17	600.51	723.89	683.35
Total Assets	57,795	44,275	40,932	36,901	34,469
Accounts Payable	153.7	97.48	164.9	134.26	144.46
Accrued Expenses	365.33	234.02	130.05	277.79	150.37
Current Portion of Long-Term Debt	2,520	-	3,900	-	-
Current Portion of Leases	48.32	173.94	175.47	235.32	214.76
Current Income Taxes Payable	19.09	79.88	77.4	87.32	-
Current Unearned Revenue	-	-	9.86	-	-
Other Current Liabilities	1,384	1,311	780.35	598.52	907.73
Total Current Liabilities	4,490	1,896	5,238	1,333	1,417
Long-Term Debt	11,850	2,400	-	3,900	3,900
Long-Term Leases	86.35	389.6	587.61	243.97	320.97
Pension & Post-Retirement Benefits	3,907	3,760	3,510	2,422	1,741
Long-Term Deferred Tax Liabilities	4.75	-	-	-	-
Other Long-Term Liabilities	295.8	335.45	284.31	152.49	98.52
Total Liabilities	20,633	8,781	9,620	8,052	7,477
Common Stock	7,189	7,189	7,189	3,595	3,595
Additional Paid-In Capital	22,646	22,646	22,646	26,259	26,259
Retained Earnings	8,968	5,851	1,680	-1,202	-2,936
Treasury Stock	-997.53	-	-	-	-
Comprehensive Income & Other	-644.61	-191.59	-203.85	197.9	74.85
Shareholders' Equity	37,161	35,494	31,311	28,850	26,992
Total Liabilities & Equity	57,795	44,275	40,932	36,901	34,469
Total Debt	14,505	2,964	4,663	4,379	4,436
Net Cash (Debt)	113.01	14,676	10,264	9,317	8,701
Net Cash Growth	-99.23%	42.98%	10.17%	7.07%	-20.97%
Net Cash Per Share	8.00	1020.31	713.81	647.93	605.15
Filing Date Shares Outstanding	14.12	14.38	14.38	14.38	14.38
Total Common Shares Outstanding	14.12	14.38	14.38	14.38	14.38
Working Capital	18,332	23,671	16,365	18,219	16,968
Book Value Per Share	2631.17	2468.50	2177.60	2006.39	1877.21
Tangible Book Value	36,959	35,363	31,280	28,785	26,891
Tangible Book Value Per Share	2616.86	2459.36	2175.44	2001.92	1870.18
Land	7,554	1,557	1,557	-	1,557
Buildings	9,068	2,974	2,974	-	2,974
Machinery	3,044	2,734	2,502	-	2,001
Construction In Progress	2,786	2,338	2,278	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.